GlycoGenesys GLGS (formerly SafeScience SAFS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GlycoGenesys GLGS (formerly SafeScience SAFS)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (10)	2/24/2004 1:21:15 PM
From: tuck	Read Replies (1) of 56

GLGS and PRW collaborate on lawyer enrichment program: >>BOSTON--(BUSINESS WIRE)--Feb. 24, 2004--GlycoGenesys, Inc., (Nasdaq: GLGS - News), a biotechnology company developing carbohydrate-based drugs, today announced that it has filed counterclaims against David Platt and Pro-Pharmaceuticals, Inc. (AMEX: PRW - News) in connection with the lawsuit commenced earlier this month by David Platt. The counterclaims include, among others, breach by David Platt of his separation agreement with the Company, tortious interference claims against Pro-Pharmaceuticals, and misappropriation of proprietary rights claims against David Platt and Pro-Pharmaceuticals. GlycoGenesys seeks monetary damages, injunctive relief to prevent David Platt and Pro-Pharmaceuticals from engaging in certain competitive activities relating to the use of polysaccharides to treat cancer and further seeks the assignment by David Platt and Pro- Pharmaceuticals of certain intellectual property to GlycoGenesys for which it claims rights.<< snip Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next